Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • AllSeq
    Registered Vendor
    • Oct 2013
    • 138

    #1

    AllSeq's 'Personalized Medicine World Conference' Interview Series

    AllSeq is excited to again be partnering with the ‘Personalized Medicine World Conference’. As a part of this partnership, we’ve been invited to interview three of the thought leaders that will be speaking at this event: Cliff Reid – CEO, Complete Genomics; Michael Snyder - Professor & Chair, Stanford Center for Genomics & Personalized Medicine; and Leroy Hood - President, Institute for Systems Biology. Through these interviews we explore the role that next generation sequencing has to play in clinical medicine, now and in the future.

    Two of the three interviews have already been posted:
    Cliff Reid discusses the impact of NGS on medicine
    Michael Snyder talks with us about ‘multiomics’ in medicine

    In early January we’ll here from Leroy Hood, who will discuss the shift to studying ‘wellness’ rather than disease.

    We hope you enjoy them!
    AllSeq - The Sequencing Marketplace
    [email protected]
    www.AllSeq.com

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...